Inducibility of the endogenous antibiotic peptide β-defensin 2 is impaired in patients with severe sepsis
2007

Impaired Inducibility of β-defensin 2 in Severe Sepsis Patients

Sample size: 34 publication Evidence: moderate

Author Information

Author(s): Malte Book, Qi Xing Chen, Lutz E. Lehmann, Sven Klaschik, Stefan Weber, Jens-Christian Schewe, Markus Luepertz, Andreas Hoeft, Frank Stuber

Primary Institution: Rheinische-Friedrich-Wilhelms University Bonn

Hypothesis

hBD2 expression is disturbed in patients with severe sepsis.

Conclusion

Ex vivo inducibility of hBD2 in peripheral blood cells from septic patients is reduced compared to healthy individuals and critically ill non-septic patients.

Supporting Evidence

  • hBD2 mRNA expression was significantly decreased in patients with severe sepsis compared to healthy controls.
  • hBD2 plasma levels in septic patients were significantly higher compared to healthy controls.
  • The study included a total of 34 individuals, providing a robust sample size for analysis.

Takeaway

Patients with severe sepsis have a harder time producing a natural antibiotic called hBD2, which helps fight infections.

Methodology

A prospective case-control study comparing hBD2 mRNA levels in patients with severe sepsis, non-septic critically ill patients, and healthy controls.

Limitations

The study had a limited number of patients and did not assess the influence of age on hBD2 inducibility.

Participant Demographics

Participants included 16 patients with severe sepsis, 9 critically ill non-septic patients, and 9 healthy individuals, all of German Caucasian origin.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc5694

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication